Ozempic in the ER: Serious Side Effects of GLP-1 Receptor Agonists

#Ozempic #GLP1 #Semaglutide #WeightLossJourney #ObesityMedicineMost Ozempic and Mounjaro side effects are just uncomfortable — but a few can land you in the ER. In this video, Dr. Mohammed Paika (board-certified internal medicine + obesity medicine physician, 15+ years as a hospitalist) breaks down which GLP-1 side effects are genuinely dangerous, who's at higher risk, and the exact red-flag symptoms you should never wait out.What's covered:Why GLP-1 side effects happen (the mechanism in plain terms)Nausea/vomiting: normal vs. red flagDehydration and acute kidney injuryDKA risk for diabetics on GLP-1sGallbladder disease and pancreatitisGastroparesis, explained without the internet hypeThe thyroid cancer warning — what the label actually meansMuscle loss: the side effect no one talks about (and how to prevent it)Mood changes and when to get helpA full red-flag quick-reference recapThis video is for education, not medical advice — always talk to your own prescriber about your specific situation.Want the full system for nutrition, protein targets, training, and side-effect management on GLP-1 medications? Join the GLP-1 Masterclass at https://drmohammedpaika.comIf this helped, subscribe for the next video on structuring protein and training week-by-week on these medications.If you or someone you know is struggling with thoughts of self-harm, call or text 988 (Suicide & Crisis Lifeline).GLP-1 Weight Loss Masterclass - https://www.drmohammedpaika.comDr. Paika Podcast - https://drmohammedpaika.transistor.fm/ Amazon Kindle - https://www.amazon.it/GLP-1-Masterclass-Physicians-Preservation-Metabolic-ebook/dp/B0GZBR8MC4Timestamps0:00 Intro0:49 Who I Am2:58 Why GLP-1 Side Effects Happen3:57 Nausea & Vomiting: Where It Usually Starts5:05 Dehydration & Acute Kidney Injury7:41 Starvation Ketosis & DKA Risk9:37 Quick Note: GLP-1 Masterclass10:17 Gallbladder Disease & Pancreatitis12:35 Gastroparesis: The Internet-Famous One14:01 The Thyroid Cancer Myth15:55 Muscle Wasting: The One I See Most Often19:13 Mood Changes & Depression21:01 Who Is At Higher Risk: The Summary21:59 The Red Flags: Quick Recap22:43 Close & Next StepsReferences:FDA Prescribing Information — Ozempic (semaglutide): [accessdata.fda.gov label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/209637s020s021lbl.pdf)FDA Prescribing Information — Mounjaro (tirzepatide): [accessdata.fda.gov label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215866s039lbl.pdf)FDA Prescribing Information — Zepbound (tirzepatide): [accessdata.fda.gov label](https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806s042lbl.pdf)(Wegovy shares the same active ingredient, semaglutide, and labeling basis as Ozempic.)Wilding JPH, et al. STEP 1 body composition sub-study — DEXA data on fat vs. lean mass loss: [J Endocr Soc](https://academic.oup.com/jes/article/5/Supplement_1/A16/6240360)Look M, et al. SURMOUNT-1 body composition sub-study — lean mass findings on tirzepatide: [Diabetes Obes Metab, 2025](https://dom-pubs.onlinelibrary.wiley.com/doi/10.1111/dom.16275)Bjerre Knudsen L, et al. Endocrinology 2010;151(4):1473-1486 — the rodent thyroid C-cell study behind the boxed warning: [Oxford Academic](https://academic.oup.com/endo/article/151/4/1473/2456651)👨‍⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine.👍 Like💬 Comment📌 Share🔔 Subscribe for more honest conversations about obesity, metabolism, hormones, and real-world health solutions⚕️ MEDICAL & EDUCATIONAL DISCLAIMERThis channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional.Viewing this content does not create a doctor-patient relationship between you and Dr. Paika.Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes.Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.